Arcus Biosciences, Inc. (RCUS)
29.85
+0.14
(+0.47%)
USD |
NYSE |
Sep 02, 16:00
29.41
-0.44
(-1.47%)
Pre-Market: 06:42
Arcus Biosciences Cash and Short Term Investments (Quarterly) : 702.00M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 702.00M |
| March 31, 2026 | 822.00M |
| December 31, 2025 | 981.00M |
| September 30, 2025 | 831.00M |
| June 30, 2025 | 911.00M |
| March 31, 2025 | 997.00M |
| December 31, 2024 | 978.00M |
| September 30, 2024 | 1.089B |
| June 30, 2024 | 969.00M |
| March 31, 2024 | 995.00M |
| December 31, 2023 | 759.00M |
| September 30, 2023 | 799.00M |
| June 30, 2023 | 930.00M |
| March 31, 2023 | 954.00M |
| December 31, 2022 | 1.009B |
| September 30, 2022 | 1.049B |
| June 30, 2022 | 1.173B |
| March 31, 2022 | 1.214B |
| Date | Value |
|---|---|
| December 31, 2021 | 499.31M |
| September 30, 2021 | 524.64M |
| June 30, 2021 | 721.01M |
| March 31, 2021 | 826.93M |
| December 31, 2020 | 728.65M |
| September 30, 2020 | 782.43M |
| June 30, 2020 | 462.47M |
| March 31, 2020 | 157.87M |
| December 31, 2019 | 188.27M |
| September 30, 2019 | 190.99M |
| June 30, 2019 | 224.40M |
| March 31, 2019 | 241.94M |
| December 31, 2018 | 256.54M |
| September 30, 2018 | 257.84M |
| June 30, 2018 | 265.70M |
| March 31, 2018 | 280.18M |
| December 31, 2017 | 175.70M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 231.00M |
| AVITA Medical, Inc. | 11.14M |
| Iovance Biotherapeutics, Inc. | 297.67M |
| Editas Medicine, Inc. | 211.64M |
| Recursion Pharmaceuticals, Inc. | 551.07M |